Anderson S - Search Results

1

Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

Komers R, Anderson S. Komers R, et al. Among authors: anderson s. Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. doi: 10.1097/00041552-200003000-00012. Curr Opin Nephrol Hypertens. 2000. PMID: 10757223 Review.

2

Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.

Komers R, Tian W, Lindsley JN, Oyama TT, Cohen DM, Anderson S. Komers R, et al. Among authors: anderson s. J Lab Clin Med. 2002 Nov;140(5):351-7. doi: 10.1067/mlc.2002.128551. J Lab Clin Med. 2002. PMID: 12434137

3

Inhibition of the renin-angiotensin system: is more better?

Anderson S, Komers R. Anderson S, et al. Kidney Int. 2009 Jan;75(1):12-4. doi: 10.1038/ki.2008.556. Kidney Int. 2009. PMID: 19092813 Free article. Review.

4

Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.

Komers R, Oyama TT, Chapman JG, Allison KM, Anderson S. Komers R, et al. Among authors: anderson s. Hypertension. 2000 Feb;35(2):655-61. doi: 10.1161/01.hyp.35.2.655. Hypertension. 2000. PMID: 10679513

5

Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.

Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S. Komers R, et al. Among authors: anderson s. Am J Physiol Renal Physiol. 2000 Sep;279(3):F573-83. doi: 10.1152/ajprenal.2000.279.3.F573. Am J Physiol Renal Physiol. 2000. PMID: 10966937 Free article.

6

Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?

Komers R, Anderson S. Komers R, et al. Among authors: anderson s. Curr Hypertens Rep. 2000 Oct;2(5):465-72. doi: 10.1007/s11906-000-0029-8. Curr Hypertens Rep. 2000. PMID: 10995522 Review.

7

Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.

Komers R, Anderson S, Epstein M. Komers R, et al. Among authors: anderson s. Am J Kidney Dis. 2001 Dec;38(6):1145-57. doi: 10.1053/ajkd.2001.29203. Am J Kidney Dis. 2001. PMID: 11728945 Review.

8

Treatment of hypertension in diabetic patients with nephropathy.

Komers R, Anderson S. Komers R, et al. Among authors: anderson s. Curr Diab Rep. 2001 Dec;1(3):251-60. doi: 10.1007/s11892-001-0043-5. Curr Diab Rep. 2001. PMID: 12643207 Review.

9

Endothelial-derived vasoactive mediators in polycystic kidney disease.

Al-Nimri MA, Komers R, Oyama TT, Subramanya AR, Lindsley JN, Anderson S. Al-Nimri MA, et al. Among authors: anderson s. Kidney Int. 2003 May;63(5):1776-84. doi: 10.1046/j.1523-1755.2003.00913.x. Kidney Int. 2003. PMID: 12675853 Free article.

10

Paradoxes of nitric oxide in the diabetic kidney.

Komers R, Anderson S. Komers R, et al. Among authors: anderson s. Am J Physiol Renal Physiol. 2003 Jun;284(6):F1121-37. doi: 10.1152/ajprenal.00265.2002. Am J Physiol Renal Physiol. 2003. PMID: 12736164 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,625 results

Search Page

Filters